This guideline covers the diagnosis and management of prostate cancer in secondary care,
including information on the best way to diagnose and identify different stages of the disease, and
how to manage adverse effects of treatment. It also includes recommendations on follow up in
primary care for people...
The incidence of primary malignant bone tumors is low, and clinical cognition is insufficient. The establishment of diagnostic criteria is of great significance for prognosis of tumors. National Comprehensive Cancer Network (NCCN) regularly publishes "Clinical Practice Guidelines for Bone Tumors" to summ...
The purpose of this guideline is to maximise the safety of patients who need radiotherapy and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for radiotherapy to patient needs if services become limited because of the COVID-19 ...
Zoon, Young Kim;
Kim, Chae Yong;
Lim, Jaejoon;
Sung, Kyoung Su;
Lee, Jihae;
Oh, Hyuk Jin;
Gu, Seok Kang;
Hyuk, Shin Kang;
Kong, Doo Sik;
Kim, Sung Hwan;
Kim, Se Hyuk;
Kim, Se Hoon;
Kim, Yu Jung;
Kim, Ah In;
Kim, Eui Hyun;
Kim, Ho Sung;
Roh, Tae Hoon;
Park, Jae Sung;
Jin Park, Hyun;
Song, Sang Woo;
Yang, Seung Ho;
Yoon, Wan Soo;
Yoon, Hong In;
Lee, Soon Tae;
Won, Sea Lee;
Lee, Youn Soo;
Wee, Chan Woo;
Chang, Jong Hee;
Jung, Tae Young;
Jung, Hye Lim;
Ho Cho, Jae;
Choi, Seung Hong;
Choi, Hyoung Soo;
Hong, Je Beom;
Lim, Do Hoon;
Chung, Dong Sup.
There was no practical guideline for the management of patients with central nervous system tumor in Korea in the past. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, developed the guideline for glioblastoma successfully and published it in Brain Tumor Research ...
Kim, Young Zoon;
Kim, Chae;
Wee, Chan Woo;
Hoon, Tae;
Hong, Je Beom;
Oh, Hyuk Jin;
Kang, Seok Gu;
Kang, Shin Hyuk;
Kong, Doo Sik;
Kim, Sung Hwan;
Kim, Se Hyuk;
Kim, Se Hoon;
Kim, Yu Jung;
Kim, Eui Hyun;
Kim, In Ah;
Ki, Ho Sung;
Park, Jae Sung;
Park, Hyun Jin;
Song, Sang Woo;
Sung, Kyoung Su;
Yang, Seung Ho;
Yoon, Wan Soon;
Yoon, Hong In;
Lee, Soon Tae;
Lee, Sea Won;
Lee, Youn Soo;
Lim, Jaejoon;
Chang, Jong Hee;
Jung, Tae Young;
Jung, Hye Lim;
Cho, Jae Ho;
Choi, Seung Hong;
Choi, Hyoung Soo;
Lim, Do Hoon;
Chung, Dong Sup.
There was no practical guideline for the management of patients with central nervous system tumor in Korea for many years. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has developed the guideline for glioblastoma. Subsequently, the KSNO guideline for World Hea...
Fassnacht, M;
Dekkers, OM;
Else, T;
Baudin, E;
Berruti, A;
de Krijger, R;
Haak, HR;
Mihai, R;
Assie, G;
Terzolo, M.
Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of patients with ACC based on the GRADE (Grading of Recomm...
Tumeurs corticosurrénaliennes,
Métastase tumorale,
Antinéoplasiques hormonaux/usage thérapeutique,
Étoposide/administration et posologie,
Mitotane/usage thérapeutique,
Doxorubicine/usage thérapeutique,
Carcinome corticosurrénalien/diagnostic,
Carcinome corticosurrénalien,
Carcinome corticosurrénalien/traitement médicamenteux,
Radiothérapie,
Cisplatine/usage thérapeutique,
Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique,
Ablation par cathéter,
Surrénalectomie,
Tumeurs corticosurrénaliennes/thérapie,
Carcinome corticosurrénalien/thérapie,
Chimioembolisation thérapeutique
This guideline covers diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over. It aims to improve care for people with non-Hodgkin's lymphoma by promoting the best tests for diagnosis and staging and the most effective treatments for 6 of the subtypes. Tests and treatments covered...
Dent, S;
Brezden-Masley, C;
Clarke, B;
Davis, MK;
Jassal, DS;
Johnson, C;
Lemieux, J;
Paterson, I;
Sebag, IA;
Simmons, C;
Sulpher, J;
Thain, K;
Thavendiranathan, P;
Wentzell, JR;
Wurtele, N;
Côté, MA;
Fine, NM;
Haddad, H;
Hayley, BD;
Hopkins, S;
Joy, AA;
Rayson, D;
Stadnick, E;
Straatman, L;
Virani, SA.
Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
Antinéoplasiques,
Marqueurs biologiques,
Cardiotoniques,
Cardiotoxines,
Troponine T,
Peptide natriurétique cérébral,
Protéine C-réactive,
Antinéoplasiques/effets indésirables,
Troubles du rythme cardiaque,
Cardiotoxicité,
Thrombose coronarienne,
Diagnostic précoce,
Échocardiographie tridimensionnelle,
Hypertension artérielle/thérapie,
IRM dynamique,
Ischémie myocardique,
Tumeurs/thérapie,
Prévention primaire,
Radiothérapie,
Facteurs de risque,
Dysfonction ventriculaire gauche,
Cardiotoxicité/diagnostic,
Cardiotoxines/effets indésirables,
Radiothérapie/effets indésirables
This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer....
